Skip to content
Screener

Merit Medical Systems MMSI Financing Cash Flow

Financing Cash Flow at other companies

Abbott logo
AbbottABT
$17.31B+942%
TFX
TeleflexTFX
-$82M-246%
Johnson & Johnson logo
Johnson & JohnsonJNJ
-$8.78B-54.9%
Stryker logo
StrykerSYK
-$95M
Delcath Systems logo
Delcath SystemsDCTH
-$2.38M-173%
Boston Scientific logo
Boston ScientificBSX
-$260M-212%

Other financials

Income statement

See full
Revenue$381.9M+7.5%
Gross profit$184.8M+7.4%
Operating income$44.2M+7.6%
Net income$41.0M+36.0%
EPS (diluted)$0.68+38.8%

Balance sheet

See full
Cash & equivalents$488.1M+23.4%
Total debt$821.6M+0.5%
Total equity$1.6B+13.9%
Total assets$2.7B+10.2%

Cash flow

See full
Operating cash flow$40.7M+0.3%
CapEx$16.0M-24.0%
Free cash flow$24.7M+26.5%

Valuation

See full
Market cap$5.24B+5.8%
Enterprise value$5.57B+2.6%
P/E37.6×-4.0×
P/S3.4×-0.1×

Profitability

See full
Gross margin48.7%+0.9pp
Operating margin12.2%+0.6pp
Net margin9%+0.2pp
FCF margin14.3%+1.3pp

Returns & leverage

See full
Return on equity9.1%0.0pp
Debt / equity0.5×-0.1×
Current ratio5.1×+0.2×

Where this comes from

Reported directly by Merit Medical Systems in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInFinancingActivities.

The source filing: Merit Medical Systems’s 10-Q, filed April 30, 2026.

Filed
Apr 30, 2026, 4:23 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0000856982-26-000025
Line item20262025
Proceeds from issuance of common stock$2,775$13,152
Contingent payments related to acquisitions(2,142)(52)
Payment of taxes related to an exchange of common stock(6,922)(6,145)
Net cash, cash equivalents, and restricted cash (used in) provided by financing activities(6,289)6,955
Effect of exchange rates on cash, cash equivalents, and restricted cash(426)936
Net increase in cash, cash equivalents and restricted cash41,70018,828
CASH, CASH EQUIVALENTS AND RESTRICTED CASH:
Beginning of period448,549378,767

Item 1. Financial Statements (Unaudited)

FAQ

What is Merit Medical Systems's financing cash flow?
Merit Medical Systems (MMSI) reported financing cash flow of -$6.29M in Q1 2026.
How has Merit Medical Systems's financing cash flow changed year-over-year?
Merit Medical Systems's financing cash flow decreased by 190.4% year-over-year, from $6.96M to -$6.29M.
What is the long-term trend for Merit Medical Systems's financing cash flow?
Over 3 years (2021 to 2025), Merit Medical Systems's financing cash flow has grown at a -45.0% compound annual growth rate (CAGR), from -$98.44M to $16.36M.
What does financing cash flow mean?
Total net cash provided by or used in financing activities — debt issuance/repayment, equity transactions, and dividend payments.

Ask your AI about Merit Medical Systems's financing cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude